Anuh Pharma MD, chairman and AGM
NSE: ANUHPHRBSE: 506260Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹79.15.
28 Oct: open ₹79.90, high ₹80.99, low ₹78.58
- Next results date: the board meets on 30 Oct 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹798 Cr1,625th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.06
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.88%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 41,73351.7% delivered
Anuh Pharma's chairperson is Arun Lalchand Todarwal, its managing director Ritesh Bipin Shah and its managing director Vivek Bipin Shah, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 12 Aug 2026.
Anuh Pharma board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonArun Lalchand Todarwal
- Managing directorRitesh Bipin Shah
- Managing directorVivek Bipin Shah
12 directors4 independent2 executive6 non-executive
- Arun Lalchand Todarwal · ChairpersonNon-executive · joined Apr 2014 · reappointed Aug 2026 · 4 listed boards · 3 as independent · 9 committee seats, 3 as chair
- Bipin Nemchand ShahNon-executive · joined Apr 2009 · reappointed Aug 2026 · 1 listed board · 2 committee seats
- Bharat Nemchand ShahNon-executive · joined Oct 1980 · reappointed Aug 2025 · 1 listed board · 1 committee seat, 1 as chair
- Samir Jayantilal ShahNon-executive · joined Aug 2016 · reappointed Aug 2024 · 1 listed board · 1 committee seat
- Ketan Lalitkumar ShahNon-executive · joined Aug 2016 · reappointed Aug 2024 · 1 listed board · 1 committee seat
- Ritesh Bipin Shah · Managing directorExecutive · joined Aug 2016 · reappointed Jan 2026 · 1 listed board · 1 committee seat
- Vivek Bipin Shah · Managing directorExecutive · joined Aug 2016 · reappointed Jan 2026 · 1 listed board
- Mita Chittaranjan DixitIndependent · joined Feb 2019 · reappointed Apr 2024 · 91 months as independent · 4 listed boards · 4 as independent · 5 committee seats, 1 as chair
- Harmanbhai Tulshibhai PatelIndependent · joined May 2019 · reappointed May 2024 · 88 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- Gaurav Satish ShahNon-executive · joined Jul 2023 · reappointed Aug 2025 · 1 listed board · 1 committee seat
- Siddharth Jasvantlal ShahIndependent · joined Apr 2024 · 30 months as independent · 1 listed board · 1 as independent · 2 committee seats
- Pradeep Hari ThakurIndependent · joined Apr 2024 · 30 months as independent · 3 listed boards · 3 as independent · 3 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 7 Aug 202612 of 12 present4 independent · 78 days in between
- 20 May 202612 of 12 present4 independent
Audit Committee
Chair Harmanbhai Tulshibhai Patel
Bipin Nemchand Shah, Arun Lalchand Todarwal, Siddharth Jasvantlal Shah, Pradeep Hari Thakur, Mita Chittaranjan Dixit
- 7 Aug 20266 of 6 present4 independent · 78 days in between
- 20 May 20266 of 6 present4 independent
Nomination and remuneration committee
Chair Mita Chittaranjan Dixit
Arun Lalchand Todarwal, Harmanbhai Tulshibhai Patel, Siddharth Jasvantlal Shah
- 20 May 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Bharat Nemchand Shah
Bipin Nemchand Shah, Ketan Lalitkumar Shah, Siddharth Jasvantlal Shah
- 7 Aug 20264 of 4 present1 independent · 78 days in between
- 20 May 20264 of 4 present1 independent
Corporate Social Responsibility Committee
Chair Siddharth Jasvantlal Shah
Bipin Nemchand Shah, Arun Lalchand Todarwal
- 7 Aug 20263 of 3 present1 independent · 78 days in between
- 20 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- JAYANTILAL THAKKAR & CO.Peer-review certificate valid to Mar 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Anuh Pharma AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Anuh Pharma dividend history
Annual general meeting, 12 Aug 2026
28,020 shareholders on the register on 5 Aug 2026; present: 17 promoters and 28 others; votes counted by Pramod Shantilal Shah / Pramod S. Shah & Associates.The company's voting result
- Adoption of Audited Financial Statements and Reports of the Board of Directors and Auditors thereon, for the financial year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Declaration of Final Dividend of Rs. 1.50/- per Equity Shares of the Company for the Financial Year 2025-26.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Re-Appointment of a Director in place of Mr. Bipin Nemchand Shah (DIN: 00083244) who retires by rotation and, being eligible seeks re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 85.04% · other public 0.04%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Re-Appointment of a Director in place of Mr. Arun Lalchand Todarwal (DIN: 00020916) who retires by rotation and, being eligible seeks re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.05%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Ratification of remuneration of Mr. Ankit Kishor Chande, Cost Accountants (Certificate of Practice No. 34051) as a Cost Auditor for the financial year 2026-27.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Revision in remuneration payable to Mr. Ritesh Bipin Shah (DIN: 02496729), Joint Managing Director of the Company for the financial year 2026-27.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.31%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Revision in remuneration payable to Mr. Vivek Bipin Shah (DIN: 02878724), Joint Managing Director of the Company for the financial year 2026-27.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.31%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Adoption of New Set of Memorandum of Association as per the provision of the Companies Act 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 85.04% · other public 0.00%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
- Adoption of New set of Alteration to Articles of Association as per the provision of the Companies Act 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 85.04% · other public 0.10%
Turnout: all 72.22% · promoters 99.79% · institutions 3.17% · other public 2.03%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 22 Aug 2025, 10 resolutions
28,753 shareholders on the register on 15 Aug 2025; present: 7 promoters and 33 others; votes counted by Pramod Shantilal Shah / Pramod S. Shah & Associates.The company's voting result
- Adoption of Audited Financial Statements and Reports of the Board of Directors and Auditors thereon, for the financial year ended March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Declaration of Final Dividend of Rs. 1.50/- per Equity Shares of the Company for the Financial Year 2024-25.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Re-Appointment of a Director in place of Mr. Bharat Nemchand Shah (DIN: 00083354) who retiresOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Re-Appointment of a Director in place of Mr. Gaurav Satish Shah (DIN: 02878186) who retires by rotation and, being eligible seeks re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Ratification of remuneration of Mr. Ankit Kishor Chande, Cost Accountants (Certificate of Practice No. 34051) as a Cost Auditor for the financial year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Appointment of M/s. GHV & Co., Practicing Company Secretaries, (Firm Registration No.: P2016MH057400) as Secretarial Auditor for the first term of five consecutive years from FY 2025-26 to FY 2029-30.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Revision in remuneration payable to Mr. Ritesh Bipin Shah (DIN: 02496729), Joint Managing Director of the Company for the financial year 2025-26.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Revision in remuneration payable to Mr. Vivek Bipin Shah (DIN: 02878724), Joint Managing Director of the Company for the financial year 2025-26.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Re-appointment of Mr. Ritesh Bipin Shah (DIN: 02496729), as Joint Managing Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
- Re-appointment of Mr. Vivek Bipin Shah (DIN: 02878724), as Joint Managing Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 70.57% · promoters 97.60% · institutions 0.00% · other public 7.73%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 6 Jul 2025, 1 resolution
24,782 shareholders on the register on 30 May 2025; votes counted by Pramod S. Shah / Pramod S. Shah & Associates.The company's voting result
- Issue of Bonus SharesOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 70.73% · promoters 97.60% · institutions 0.00% · other public 8.29%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 12 Aug 2026, 2 fund houses
- Adoption of Audited Financial Statements and Reports of the Board of Directors and Auditors thereon, for the financial year ended March 31, 2026.2 for0 against
- Declaration of Final Dividend of Rs. 1.50/- per Equity Shares of the Company for the Financial Year 2025-26.2 for0 against
- Re-Appointment of a Director in place of Mr. Bipin Nemchand Shah (DIN: 00083244) who retires by rotation and, being eligible seeks re-appointment.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundNo concern identified on merit of proposed appointee. Non-compliance with Regulation 17(1A) of SEBI LODR Regulations: Reappointment proposed via Ordinary Resolution for director beyond the age of 75 years.
0 for2 against - Re-Appointment of a Director in place of Mr. Arun Lalchand Todarwal (DIN: 00020916) who retires by rotation and, being eligible seeks re-appointment.2 for0 against
- Ratification of remuneration of Mr. Ankit Kishor Chande, Cost Accountants (Certificate of Practice No. 34051) as a Cost Auditor for the financial year 2026-27.2 for0 against
- Revision in remuneration payable to Mr. Ritesh Bipin Shah (DIN: 02496729), Joint Managing Director of the Company for the financial year 2026-27.2 for0 against
- Revision in remuneration payable to Mr. Vivek Bipin Shah (DIN: 02878724), Joint Managing Director of the Company for the financial year 2026-27.2 for0 against
- Adoption of New Set of Memorandum of Association as per the provision of the Companies Act 2013.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Transparency & Governance Concern: Updated AoA not disclosed / cannot be located
0 for2 against - Adoption of New set of Alteration to Articles of Association as per the provision of the Companies Act 2013.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Transparency & Governance Concern: Updated AoA not disclosed / cannot be located
0 for2 against
Mutual fund votes, meeting of 18 Aug 2023, 1 fund house
Appointment of Mr. Arun L. Todarwal (DIN: 00020916) as a Non-Executive Non Independent Director, Chairman of the Company w.e.f. 1st April , 2024 upon his ceasing to be the Non-Executive, Independent Director of the Company.MoreLess
1 for0 against- Appointment of Mr. Gaurav Shah (DIN: 02878186) as an Non Independent, Non-Executive Director of the Company whose period of office shall be liable to retire by rotation.1 for0 against
Appointment of Mr. Pradeep Thakur (DIN: 00685992) as an Independent Director of the Company for 5 (Five) consecutive years to hold office from 1st April, 2024 to 31st March, 2029 whose period of office shall not be liable to retire by rotation.MoreLess
1 for0 againstAppointment of Mr. Siddharth Shah (DIN: 00004958) as an Independent Director of the Company for 5 (Five) consecutive years to hold office from 1st April, 2024 to 31st March, 2029 whose period of office shall not be liable to retire by rotation.MoreLess
1 for0 against- Approve material related party transaction with S. Kant Chemicals Pvt. Ltd for the amount in aggregate not exceeding Rs.100 Crores per annum.1 for0 against
Ratification of remuneration of Rs.1,20,000/- plus applicable tax and reimbursement of the out of pocket expenses payable to Mr. Ankit Kishor Chande, Cost Accountant, (Certificate of Practice No. 34051) being a Cost Auditor, to conduct the audit of the Cost Accounting records related to Bulk Drugs of the Company for the Financial Year 2023-24.MoreLess
1 for0 againstRe-appointment of Dr. Mita C. Dixit (DIN 08198165) as an Independent Director of the Company, not subject to retirement by rotation, for a term of 5 (Five) consecutive years effective from 1st April, 2024 to 31st March, 2029.MoreLess
1 for0 againstRe-appointment of Mr. Harmanbhai Tulsibhai Patel (DIN 07342390) as an Independent Director of the Company, not subject to retirement by rotation, for a term of 5 (Five) consecutive years effective from 22nd May, 2024 to 21st May, 2029.MoreLess
1 for0 against- Revision in the remuneration of Mr. Ritesh B. Shah (DIN: 02496729), Joint Managing Director of the Company w.e.f. 1st April, 2023 for the financial year 2023-24.1 for0 against
- Revision in the remuneration of Mr. Vivek Shah (DIN: 02878724), Joint Managing Director of the Company w.e.f. 1st April, 2023 for the financial year 2023-24.1 for0 against
- To appoint a Director in place of Mr. Bipin N. Shah (DIN: 00083244) who retires by rotation and, being eligible offers himself for re-appointment.1 for0 against
- To declare a Final Dividend of Rs.2/- per Equity Share of the Company for the Financial Year 2022-23.1 for0 against
To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2023, including Audited Balance Sheet as on March 31, 2023 and the Statement of Profit & Loss for the year ended on that date together with the Reports of the Board of Directors and Auditors thereon for the said year.MoreLess
1 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines, tax disputes and stakes in unlisted companies
Reported in the filing for the quarter to Sep 2026.
- Unlisted stake heldHUOBAN ENERGY 5 PRIVATE LIMITEDSince 28 Nov 2024
0.00% bought in the quarter; holding 9.14%, from 9.14%
- Fine or penaltyIncome Tax Act, 1961Since 18 Sep 2026
Demand Order under section 156
On account of disallowances of certain deductions claimed under various provision of the Income Tax Act for AY 2018-19. - Tax disputeDy. Commissioner of Customs, JNCH, Nhava ShevaSince 16 Nov 2021Pending before Bombay High Court for further hearing , Interim relief grantedAt the filing before: Pending before Bombay High Court for further hearing, Interim relief granted
- Tax disputeDy. Commissioner of Income Tax (AY 2017-18)Since 24 Apr 2021Pending before CIT(Appeal) for hearing
- Tax disputeDy. Commissioner of Income Tax (AY 2018-19)Since 21 Oct 2022Pending before CIT(Appeal) for hearing
- Tax disputeBombay Sales Tax Act,1959Since 12 Jan 1998Pending before Bombay High Court for further hearing
- Tax disputeCentral Sales Tax Act, 1956Since 12 Jan 1998Pending before Bombay High Court for further hearing
- Tax disputeBombay Sales Tax Act,1959Since 4 Apr 1997Pending before Bombay High Court for further hearing
6 more
- Tax disputeCentral Sales Tax Act, 1956Since 4 Apr 1997Pending before Bombay High Court for further hearing
- Tax disputeGoods and Service Tax Act, 2017Since 4 Feb 2025Company in process of filling WRIT petition challanging the demand order.
- Tax disputeCustom Tariff Act, 1975Since 23 Jun 2025Suitable Action may be taken
- Tax disputeIncome Tax Act, 1961Since 20 Jan 2026Pending before Appellate TribunalAt the filing before: Suitable Action may be taken
- Tax disputeIncome Tax Act, 1961Since 18 Jun 2026Suitable Action may be taken
- Tax disputeIncome Tax Act, 1961Since 18 Sep 2026Suitable Action may be taken
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.